Business
– Barclays analyst Douglas Tsao sees the success of double-dose Copaxone as a platform for expansion. – “The mergers and acquisition phenomenon is one...
Hi, what are you looking for?
– Barclays analyst Douglas Tsao sees the success of double-dose Copaxone as a platform for expansion. – “The mergers and acquisition phenomenon is one...
– Entrepreneur and shareholder Benny Landa continues to cause trouble for Teva. – Israel’s largest company and the world’s largest manufacturer of generic medications, pharmaceutical...
– – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has reached settlements with Sandoz, Actavis, Lupin and Apotex with respect to U.S. Patent 7, 132, 570...
– Yossi Beinart feels that quick exits by new companies are hurting Israel’s future. – Israel has become an “exit nation”, where the goal...
– Teva Pharmaceuticals has been sued by the City of Chicago for its prescription pain killers. – – The Israeli pharmaceutical giant Teva is...
– “Bloomberg” says investors are wondering how long Teva can stay out of the game. “Drugmakers on an acquisition spree have created...
– Chairman and CEO Phillip Frost: From an R&D perspective, all our programs are progressing. – – – Opko Health Inc. (NYSE: OPK; TASE: OPK) reported higher...
– (Was Originally Published at Knowlegde@Wharton) – On 11 February, when Erez Vigodman stepped into the corner office at Teva Pharmaceutical Industries, he didn’t come...
– Teva earned lower profits on flat revenue for 2013, but beat the analysts’ consensus. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today reported...
– The burn and wound treatment company MediWound plans to raise $100m on Nasdaq at a $400 million valuation. – In the coming weeks, several Israeli...